Unique B cell differentiation profile in tolerant kidney transplant patients

American Journal of Transplantation

Volumn 14, Issue 1, 2014, Pages 144-155

  Chesneau, M ^a,b   Pallier, A ^a   Braza, F ^a,b   Lacombe, G ^c,d   Le Gallou, S ^c   Baron, D ^a   Giral, M ^a,b,e   Danger, R ^a,b   Guerif, P ^e   Aubert Wastiaux, H ^e   Neel A ^a,b,e   Michel, L ^a,b,e   Laplaud, D A ^a,b,e   Degauque, N ^a   Soulillou, J P ^a,b,e   Tarte, K ^c   Brouard, S ^a,b,e  

^a Centre National de la Recherche Scientifique   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; B cells; cytokine; differentiation; tolerance; transplantation

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 10; INTERLEUKIN 6; SYNDECAN 1;

ADULT; AGED; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE DIFFERENTIATION; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; PHENOTYPE; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPLANTATION TOLERANCE; VERY ELDERLY; YOUNG ADULT;

APOPTOSIS; B CELLS; CYTOKINE; DIFFERENTIATION; TOLERANCE; TRANSPLANTATION;

ADULT; ANTIGENS, CD; APOPTOSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PLASMA CELLS;

EID: 84891015845     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12508     Document Type: Article

References (42)

1. Jovanovic V, Lair D, Soulillou J-P, Brouard S., Transfer of tolerance to heart and kidney allografts in the rat model. Transpl Int 2008; 21: 199-206.
2. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
3. Poirier N, Blancho G, Vanhove B., Alternatives to calcineurin inhibition in renal transplantation: Belatacept, the first co-stimulation blocker. Immunotherapy 2010; 2: 625-636.
4. Leonard DA, Cetrulo CL Jr, McGrouther DA, Sachs DH., Induction of tolerance of vascularized composite allografts. Transplantation 2013; 95: 403-409.
5. Leventhal J, Abecassis M, Miller J, et al. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: Durable chimerism predicts outcome. Transplantation 2013; 95: 169-176.
6. Roussey-Kesler G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006; 6: 736-746.
7. Brouard S, Pallier A, Renaudin K, et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012; 12: 3296-3307.
8. + T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398-407.
9. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448-15453.
10. Pallier A, Hillion S, Danger R, et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010; 78: 503-513.
11. Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836-1847.
12. Sagoo P, Perucha E, Sawitzki B, et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848-1861.
13. Gallou SL, Caron G, Delaloy C, Rossille D, Tarte K, Fest T., IL-2 requirement for human plasma cell generation: Coupling differentiation and proliferation by enhancing MAPK-ERK signaling. J Immunol 2012; 189: 161-173.
14. Perfetto SP, Chattopadhyay PK, Roederer M., Seventeen-colour flow cytometry: Unravelling the immune system. Nat Rev Immunol 2004; 4: 648-655.
15. Lamirault G, Meur NL, Roussel J-C, et al. Molecular risk stratification in advanced heart failure patients. J Cell Mol Med 2010; 14: 1443-1452.
16. Baron D, Bihouée A, Teusan R, et al. MADGene: Retrieval and processing of gene identifier lists for the analysis of heterogeneous microarray datasets. Bioinformatics 2011; 27: 725-726.
17. Eisen MB, Spellman PT, Brown PO, Botstein D., Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.
18. Zeeberg BR, Feng W, Wang G, et al. GoMiner: A resource for biological interpretation of genomic and proteomic data. Genome Biol 2003; 4: R28.
19. Lozano JJ, Pallier A, Martinez-Llordella M, et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011; 11: 1916-1926.
20. Eynon EE, Parker DC., Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992; 175: 131-138.
21. Chung JB, Wells AD, Adler S, Jacob A, Turka LA, Monroe JG., Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: Implications for peripheral B and T cell responsiveness. J Immunol 2003; 171: 1758-1767.
22. Chen X, Jensen PE., Cutting edge: Primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol 2007; 179: 2046-2050.
23. Reichardt P, Dornbach B, Rong S, et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007; 110: 1519-1529.
24. Fuchs EJ, Matzinger P., B cells turn off virgin but not memory T cells. Science 1992; 258: 1156-1159.
25. Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182: 3492-3502.
26. Lemoine S, Morva A, Youinou P, Jamin C., Human T cells induce their own regulation through activation of B cells. J Autoimmun 2011; 36: 228-238.
27. Jourdan M, Caraux A, Caron G, et al. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J Immunol 2011; 187: 3931-3941.
28. Huggins J, Pellegrin T, Felgar RE, et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007; 109: 1611-1619.
29. Choe J, Kim HS, Zhang X, Armitage RJ, Choi YS., Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis. J Immunol 1996; 157: 1006-1016.
30. Heidt S, Hester J, Shankar S, Friend PJ, Wood KJ., B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant 2012; 12: 1784-1792.
31. Knechtle SJ, Pascual J, Bloom DD, et al. Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: Clinical results and immune monitoring. Am J Transplant 2009; 9: 1087-1098.
32. Pasare C, Medzhitov R., Control of B-cell responses by toll-like receptors. Nature 2005; 438: 364-368.
33. Barr TA, Shen P, Brown S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012; 209: 1001-1010.
34. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180: 4763-4773.
35. Kaminski DA, Wei C, Qian Y, Rosenberg AF, Sanz I., Advances in human B cell phenotypic profiling. Front Immunol 2012; 3: 302.
36. Matz M, Lehnert M, Lorkowski C, et al. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation. Transpl Int 2012; 25: 1106-1116.
37. Fuleihan R, Ramesh N, Horner A, et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994; 93: 1315-1320.
38. Liu C, Noorchashm H, Sutter JA, et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 2007; 13: 1295-1298.
39. Haynes LD, Jankowska-Gan E, Sheka A, et al. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant 2012; 12: 640-648.
40. Baeten D, Louis S, Braud C, et al. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006; 17: 294-304.
41. Coelho V, Saitovitch D, Kalil J, Silva HM., Rethinking the multiple roles of B cells in organ transplantation. Curr Opin Organ Transplant 2013; 18: 13-21.
42. Silva HM, Takenaka MCS, Moraes-Vieira PMM, et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med 2012; 18: 733-743.